Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Ingrid, Furlan"'
Autor:
Lusine V. Navasardyan, Ingrid Furlan, Stephanie Brandt, Ansgar Schulz, Martin Wabitsch, Christian Denzer
Publikováno v:
Italian Journal of Pediatrics, Vol 49, Iss 1, Pp 1-10 (2023)
Abstract Background Shwachman-Diamond syndrome (SDS) is a rare congenital disorder caused by mutations in the SBDS gene and characterized by exocrine pancreatic deficiency, hematologic dysfunction, and skeletal growth failure. Although the hematologi
Externí odkaz:
https://doaj.org/article/0496082a937d46b28f99ccc85aad6737
Publikováno v:
EJC Paediatric Oncology, Vol 2, Iss , Pp 100082- (2023)
Externí odkaz:
https://doaj.org/article/c14e431259d849e992254a01d04aeed7
Autor:
Klaus-Michael Debatin, Ingrid Furlan, Orly Elpeleg, Donald Bunjes, Meinrad Beer, Catharina Schuetz, Stephanie von Harsdorf, Batia Avni, Sigal Grisariu, Polina Stepensky, Bella Shadur, Ansgar Schulz, Irina Zaidman, Manfred Hoenig, Mehtap Sirin
Osteopetrosis (OP) is a rare disease caused by defective osteoclast differentiation or function. Hematopoietic stem cell transplantation (HSCT) is the only curative treatment available in the infantile “malignant” form of OP. Improved clinical an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc4833fa953f1355081b779ead2182f1
https://europepmc.org/articles/PMC6436016/
https://europepmc.org/articles/PMC6436016/
Autor:
Markus G. Seidel, Manfred Hoenig, Catharina Schuetz, Katharina Kleinschmidt, Fabian Hauck, Michael H. Albert, Britta Maecker-Kolhoff, Joachim Roesler, Ingrid Furlan, Ansgar Schulz, Eva-Maria Jacobsen, Britta Eiz-Vesper, Meinolf Suttorp, Klaus-Michael Debatin
Publikováno v:
Transplantation and Cellular Therapy. 27:93.e1-93.e8
Patients with primary immunodeficiencies caused by severe defects in T cell immunity are at risk of acquiring life-threatening infections. Cellular therapies are necessary to establish normal T cell function and to allow for long-term survival. This
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed9b0e3e086535b10c391042da94d6cd
https://doi.org/10.1016/j.bbmt.2020.09.037
https://doi.org/10.1016/j.bbmt.2020.09.037
Autor:
Ingrid Furlan, Eva-Maria Jacobsen, Catharina Schuetz, Klaus-Michael Debatin, Ansgar Schulz, Susanna M. Müller-Langer, Manfred Hönig, Wilhelm Friedrich, Mehtap Sirin, Klaus Schwarz, Ulrich Pannicke, Markus J. Ege
Publikováno v:
The Journal of allergy and clinical immunology. 143(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2dbf6a11b2cb4dc804120bccf74aebbf
https://pubmed.ncbi.nlm.nih.gov/30529243
https://pubmed.ncbi.nlm.nih.gov/30529243
Autor:
M Suttorp, Marry M. van den Heuvel-Eibrink, Andreas E. Kulozik, Ayami Yoshimi, Michael Dworzak, Annamaria Cseh, Lale Olcay, Ingrid Furlan, Andrea Candás, Franco Locatelli, Charlotte M. Niemeyer, Brigitte Strahm, Henrik Hasle, Riccardo Masetti, Christian Flotho, Ute Groß-Wieltsch, Markus Schmugge
Publikováno v:
Blood, 125(14), 2311-2313. American Society of Hematology
Cseh, A, Niemeyer, C M, Yoshimi, A, Dworzak, M, Hasle, H, van den Heuvel-Eibrink, M M, Locatelli, F, Masetti, R, Schmugge, M, Groß-Wieltsch, U, Candás, A, Kulozik, A E, Olcay, L, Suttorp, M, Furlan, I, Strahm, B & Flotho, C 2015, ' Bridging to transplant with azacitidine in juvenile myelomonocytic leukemia : a retrospective analysis of the EWOG-MDS study group ', Blood, vol. 125, no. 14, pp. 2311-3 . https://doi.org/10.1182/blood-2015-01-619734
Cseh, A, Niemeyer, C M, Yoshimi, A, Dworzak, M, Hasle, H, van den Heuvel-Eibrink, M M, Locatelli, F, Masetti, R, Schmugge, M, Groß-Wieltsch, U, Candás, A, Kulozik, A E, Olcay, L, Suttorp, M, Furlan, I, Strahm, B & Flotho, C 2015, ' Bridging to transplant with azacitidine in juvenile myelomonocytic leukemia : a retrospective analysis of the EWOG-MDS study group ', Blood, vol. 125, no. 14, pp. 2311-3 . https://doi.org/10.1182/blood-2015-01-619734
To the editor: DNA methyltransferase-inhibiting azanucleosides have become a mainstay of treatment of myeloid neoplasms in adult patients,[1][1] with 5-azacytidine (azacitidine) being the agent in broadest clinical use. Although not curative, treatme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d65e89919b2f58a316cf9f88cb294482
https://doi.org/10.1182/blood-2015-01-619734
https://doi.org/10.1182/blood-2015-01-619734
Autor:
Mary M. van den Heuvel-Eibrink, Ayami Yoshimi, Owen P. Smith, Christian Flotho, Brigitte Strahm, Annamaria Cseh, Charlotte M. Niemeyer, Albert Català, Melchior Lauten, Lale Olcay, Michael C. Frühwald, Andreas E. Kulozik, Bernd Gruhn, M Suttorp, Markus Metzler, Toralf Bernig, Henrik Hasle, Ingrid Furlan, Barbara De Moerloose
Publikováno v:
Cseh, A M, Niemeyer, C M, Yoshimi, A, Catala, A, Frühwald, M C, Hasle, H, van den Heuvel-Eibrink, M M, Lauten, M, De Moerloose, B, Smith, O P, Bernig, T, Gruhn, B, Kulozik, A E, Metzler, M, Olcay, L, Suttorp, M, Furlan, I, Strahm, B & Flotho, C 2016, ' Therapy with low-dose azacitidine for MDS in children and young adults : a retrospective analysis of the EWOG-MDS study group ', British Journal of Haematology, vol. 172, no. 6, pp. 930-6 . https://doi.org/10.1111/bjh.13915
Low-dose azacitidine is efficient and safe in the therapy of malignant myeloid disorders in adults but data in children are lacking. We present a retrospective analysis of 24 children and young adults with myelodysplastic syndrome (MDS) who received
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e912163413b938b6114b681b31b0aab
https://pure.au.dk/portal/da/publications/therapy-with-lowdose-azacitidine-for-mds-in-children-and-young-adults(0fb5a6aa-1bfe-4ae4-b994-e1f714d1deb5).html
https://pure.au.dk/portal/da/publications/therapy-with-lowdose-azacitidine-for-mds-in-children-and-young-adults(0fb5a6aa-1bfe-4ae4-b994-e1f714d1deb5).html
Autor:
Roos J Leguit, Valerie de Haas, Pascale De Paepe, Monika Führer, Charlotte M. Niemeyer, Stephan Schwarz, Judit Csomor, Peter Noellke, Sonja Behrendt, Irith Baumann, Gitte Kerndrup, Vit Campr, Ingrid Furlan
Publikováno v:
Histopathology. 61:10-17
Baumann I, Fuhrer M, Behrendt S, Campr V, Csomor J, Furlan I, de Haas V, Kerndrup G, Leguit R J, De Paepe P, Noellke P, Niemeyer C & Schwarz S (2012) Histopathology 61, 10–17 Morphological differentiation of severe aplastic anaemia from hypocellula
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fb2527be3177d3da6a77c1ac2780cf03
https://doi.org/10.1111/j.1365-2559.2011.04156.x
https://doi.org/10.1111/j.1365-2559.2011.04156.x
Autor:
Ingrid Furlan, Rosely Oliveira Godinho
Publikováno v:
British Journal of Pharmacology. 146:389-396
This study analyzed the expression of muscarinic acetylcholine receptors (mAChRs) in the rat cultured skeletal muscle cells and their coupling to G protein, phospholipase C and adenylyl cyclase (AC). Our results showed the presence of a homogeneous p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3bfcc4b78d48f3defe19303bde0a5894
https://doi.org/10.1038/sj.bjp.0706329
https://doi.org/10.1038/sj.bjp.0706329
Autor:
Irith, Baumann, Monika, Führer, Sonja, Behrendt, Vit, Campr, Judit, Csomor, Ingrid, Furlan, Valérie, de Haas, Gitte, Kerndrup, Roos J, Leguit, Pascale, De Paepe, Peter, Noellke, Charlotte, Niemeyer, Stephan, Schwarz
Publikováno v:
Histopathology. 61(1)
To evaluate the reproducibility and reliability of the histomorphological criteria differentiating severe aplastic anaemia (SAA) and hypoplastic refractory cytopenia of childhood (RCC), the most frequently acquired hypocellular bone marrow conditions
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0b19732d5e51e3a89b2aaef2c172932e
https://pubmed.ncbi.nlm.nih.gov/22458667
https://pubmed.ncbi.nlm.nih.gov/22458667